In possibly dramatic research and developing, Speedboat Inject, Chepstow based Creo Medical’s endoscopic alternative to traditional surgery in the bowel has been added to the NHS Wales framework.
With its unique 5-in-1 functionality, and by using both advanced bipolar energy and microwave energy through a single power source, the miniscule device is able to remove pre-cancerous lesions in the bowel as a day case as opposed to a surgical operation.
This means that those treated by Speedboat Submucosal Dissection (SSD) typically do so without the need for general anesthetic, without the traditional side effects or aftereffects of surgery, with better patient outcomes and with patients able to be treated far quicker – often leaving the same day.
This is turn has significant potential benefits to NHS hospitals, with cost savings of £10k per procedure compared to traditional surgery and associated freed up bed spaces and reduced waiting lists.
The device, powered by Creo Medical’s multi-patented Kamaptive Technology, is already treating patients across the World and was recently also added to the NHS England framework – where it has been adopted by numerous hospitals. It will now be readily available to NHS Wales healthcare providers, with Creo Medical opening up further training opportunities to satisfy the post-Covid backlog of interest.
Tell us your thoughts in the Facebook post and share this with your friends.